Latest Boardroom Shifts News

Vitura Health’s telehealth arm, Doctors on Demand, has hit a major milestone of over 1 million consultations since FY2024, while delivering sustained EBITDA profitability and a 54% revenue increase over two years to $21.6 million in FY2026 Q1-Q3.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

Energy World Corporation is accelerating development of its Pagbilao LNG terminal while launching a strategic review focused on monetising Siemens turbines amid evolving power market dynamics and strong U.S. demand.

RPM Automotive has appointed Roy Norris as its new CEO, replacing Clive Finkelstein who served since September 2024. Norris brings extensive industry experience aimed at steering RPM's strategic growth.

Xenora Minerals has committed to the next stage of its Dudley Lithium Project earn-in, revealing new lithium anomalies using enhanced soil sampling techniques. Meanwhile, the company navigates a key leadership change with a new managing director appointed.

Trade Window Holdings has announced the unexpected resignation of founding CEO AJ Smith due to illness, with COO Dewald van Rensburg stepping in as acting CEO. The board is currently evaluating options for a permanent replacement.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

IRIS Metals has fortified its balance sheet with a A$5.5 million placement and is progressing towards an updated lithium-rubidium resource at Beecher while executing a farm-in deal for a tungsten project in Montana, reinforcing its diversified US critical minerals strategy.

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

Nutritional Growth Solutions has appointed director Manik Pujara as interim CEO and CFO, replacing Andrew Grover who remains as nonexecutive chair. This leadership shuffle coincides with ongoing exploration of corporate opportunities.

Lightning Minerals pivots to a gold-led Australian strategy, elevating its Mt Turner Project as the core value driver while shedding non-core lithium assets. The company aims to capitalise on strong initial drilling success and disciplined capital allocation amid evolving commodity cycles.